Morepen Laboratories has sold around 36.7 million Blood Glucose testing strips in Q1 FY 2019-20 as against 27.4 million glucose strips sold in the corresponding quarter of the previous fiscal, thus registering a growth of 34%. The company has achieved a milestone of selling 325 million glucose testing strips till the end of the quarter under consideration in the current fiscal.
Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.
